Clinical Case Reports (Sep 2022)

Complete response to intravesical gemcitabine in non‐muscle invasive bladder cancer patient after BCG failure: A case report and literature review

  • Fouad Nahhat,
  • Modar Doyya,
  • Hazem Ksiri

DOI
https://doi.org/10.1002/ccr3.6373
Journal volume & issue
Vol. 10, no. 9
pp. n/a – n/a

Abstract

Read online

Abstract Bladder cancer treatment remains a challenge to every oncologist. We report the case of a 57‐year‐old man with BCG‐refractory bladder cancer who had a complete response to intravesical gemcitabine to highlight the role of gemcitabine as a bladder sparing treatment in BCG‐failure patients.

Keywords